Low vasculitis risk with TNF inhibitors
GLASGOW – Treatment with tumor necrosis factor (TNF) inhibitors for rheumatoid arthritis is associated with a low risk of vasculitis-like events, according to a large analysis of data from the United... (Source: Rheumatology News)
Source: Rheumatology News - May 10, 2016 Category: Rheumatology Source Type: research

Vascular disease linked to sight loss in giant cell arteritis
GLASGOW – People with giant cell arteritis may be more likely to go blind if they have underlying vascular disease, according to an analysis of the Diagnostic and Classification Criteria in... (Source: Rheumatology News)
Source: Rheumatology News - May 10, 2016 Category: Rheumatology Source Type: research

Macitentan falls short to stop digital ulcers in systemic sclerosis
Macitentan failed to reduce digital ulcers in systemic sclerosis patients in a pair of randomized trials including approximately 500 adults. The findings were published online May 10 in JAMA.... (Source: Rheumatology News)
Source: Rheumatology News - May 10, 2016 Category: Rheumatology Source Type: research

TRACTISS ends rituximab hopes for Sjögren’s syndrome
GLASGOW – Rituximab is unlikely to work as a treatment for Sjögren’s syndrome, according to a sneak peak of results from a multicenter study. The study, the Trial of Anti–B Cell Therapy in Patients... (Source: Rheumatology News)
Source: Rheumatology News - May 9, 2016 Category: Rheumatology Source Type: research

Simple signs could signal complex pain syndrome
GLASGOW – Two novel clinical signs can be used to determine whether people who have had a fracture are likely to develop complex regional pain syndrome, a condition for which there is currently no... (Source: Rheumatology News)
Source: Rheumatology News - May 9, 2016 Category: Rheumatology Source Type: research

Study backs moderate alcohol intake for MTX patients
GLASGOW – Advising patients with rheumatoid arthritis who are being treated with methotrexate to moderate their alcohol intake remains sound advice, the results of a large clinical database study... (Source: Rheumatology News)
Source: Rheumatology News - May 9, 2016 Category: Rheumatology Source Type: research

Phone coaching adds limited benefits in knee osteoarthritis
Adding telephone coaching to a home-based physiotherapist-prescribed activity program does not increase the pain and function benefits of such a program alone in knee osteoarthritis, a randomized... (Source: Rheumatology News)
Source: Rheumatology News - May 8, 2016 Category: Rheumatology Source Type: research

Adolescent knee pain ‘not benign,’ linked to later OA
GLASGOW – Older adults are more than seven times as likely to develop knee osteoarthritis if they had anterior knee pain as adolescents, according to the results of a case-control study. The... (Source: Rheumatology News)
Source: Rheumatology News - May 7, 2016 Category: Rheumatology Source Type: research

Brodalumab effective for rare, severe types of psoriasis
The investigational interleukin-17 inhibitor brodalumab was safe and effective in a small phase III Japanese study of adults with two rare and severe types of psoriasis, generalized pustular... (Source: Rheumatology News)
Source: Rheumatology News - May 6, 2016 Category: Rheumatology Source Type: research

Opioid-based therapies reduce TKA needs for OA patients, but not costs
Treatment with opioids is not cost effective in osteoarthritis patients without comorbidities, according to Savannah R. Smith and her associates. When a 10% reduction in total knee arthroplasty... (Source: Rheumatology News)
Source: Rheumatology News - May 6, 2016 Category: Rheumatology Source Type: research

ABIM announces shorter MOC assessment
WASHINGTON – Shorter, more frequent MOC assessments are coming to an office or home computer near you under a new American Board of Internal Medicine certification option announced May 5 at the... (Source: Rheumatology News)
Source: Rheumatology News - May 5, 2016 Category: Rheumatology Source Type: research

VIDEO: Secrets of success in a MACRA-based world
WASHINGTON – Are you ready for the way you are paid for seeing patients to change, and not just change, but change dramatically? The value-based care system of reimbursement for primary care... (Source: Rheumatology News)
Source: Rheumatology News - May 5, 2016 Category: Rheumatology Source Type: research

VIDEO: Value-based care 101
WASHINGTON – Feel free to continue operating under a fee-for-service system, but according to Neil Kirschner, Ph.D., the senior associate for regulatory and insurer affairs at the American College of... (Source: Rheumatology News)
Source: Rheumatology News - May 5, 2016 Category: Rheumatology Source Type: research

FDA panels recommend expanding REMS, requiring prescriber education, for ER/LA opioids
Two Food and Drug Administration advisory committees have unanimously agreed that the current risk evaluation and mitigation strategy (REMS) for extended-release and long-acting opioid analgesic... (Source: Rheumatology News)
Source: Rheumatology News - May 4, 2016 Category: Rheumatology Source Type: research

Tofacitinib an alternative treatment for refractory cutaneous dermatomyositis
Tofacitinib, an oral Janus kinase (JAK)-1/3 inhibitor approved for treating rheumatoid arthritis, was beneficial in treating cutaneous dermatomyositis in three patients who had failed traditional... (Source: Rheumatology News)
Source: Rheumatology News - May 4, 2016 Category: Rheumatology Source Type: research